Heritage Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.04M Buy
16,629
+9,998
+151% +$800K 0.1% 168
2025
Q4
$632K Buy
6,631
+4,446
+203% +$436K 0.06% 192
2025
Q3
$213K Buy
2,185
+140
+7% +$14.5K 0.02% 291
2025
Q2
$220K Hold
2,045
0.03% 285
2025
Q1
$206K Buy
+2,045
New +$206K 0.03% 290
2022
Q1
Sell
-12,310
Closed -$523K 246
2021
Q4
$523K Sell
12,310
-151
-1% -$6.34K 0.07% 183
2021
Q3
$541K Sell
12,461
-221
-2% -$9.78K 0.08% 174
2021
Q2
$542K Sell
12,682
-16,421
-56% -$691K 0.08% 175
2021
Q1
$1.13M Sell
29,103
-820
-3% -$31K 0.17% 118
2020
Q4
$1.08M Sell
29,923
-3,544
-11% -$128K 0.17% 115
2020
Q3
$1.28M Sell
33,467
-514
-2% -$19.8K 0.24% 97
2020
Q2
$1.19M Buy
33,981
+22,909
+207% +$825K 0.23% 96
2020
Q1
$362K Hold
11,072
0.09% 142
2019
Q4
$501K Buy
11,072
+4,350
+65% +$182K 0.1% 135
2019
Q3
$274K Buy
+6,722
New +$285K 0.06% 163

Other funds holding BSX

Heritage Trust's BSX Position: Q1 2026 in Review

Heritage Trust increased its Boston Scientific (BSX) stake by 151% in Q1 2026, buying an estimated $800K and bringing the position to 16,629 shares worth $1.04M. The position accounts for 0.1% of the portfolio, ranked #168.

Heritage Trust first reported a position in BSX in Q3 2019 and has held it in 15 quarters since. The position peaked at $1.28M in Q3 2020. 1,665 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Heritage Trust held 16,629 shares of Boston Scientific worth $1.04M as of Q1 2026.
  • Heritage Trust bought 9,998 Boston Scientific shares in Q1 2026, an estimated $800K.
  • Boston Scientific made up 0.1% of Heritage Trust's portfolio in Q1 2026, its #168 holding.
  • Heritage Trust first reported a position in Boston Scientific in Q3 2019 and has held it in 15 quarters since.
  • Heritage Trust's Boston Scientific position peaked at $1.28M in Q3 2020.
  • 1,665 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Heritage Trust's 13F filing for Q1 2026, filed 13 May 2026.